BridgeMD
Compares treatment options for Moderate to Severe Vernal Keratoconjunctivitis
Official title A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
ClinicalTrials.gov ID: NCT07169695
What this study is testing
What is T1695?
T1695 is an investigational medicine, being studied as a potential treatment for moderate to severe vernal keratoconjunctivitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 17
You may be able to join if
- Main
- Informed consent signed and dated
- Male or female participant from 4 years to less than 18 years old.
- Participant with grading score of 3 or 4 on the Bonini scale for clinical grading of VKC in each eye. Main
You likely can't join if
- Participants must not have any conditions which might exclude them from participating, could interfere with the study, or pose an unacceptable risk...
The study team makes the final eligibility decision.
Where it's taking place
- Kolkata, West Bengal, India
- Ahmedabad, India
- Bangalore, India
- Hyderabad, India
- Jaipur, India
- Kolkata, India
- Patna, India
- Pune, India
- Surat, India
- Visakhapatnam, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kolkata, West Bengal, India; Ahmedabad, India; Bangalore, India; Hyderabad, India; Jaipur, India; Kolkata, India and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.